Article
Clinical-Trial Prediction Markets Have Arrived. Their Credibility Will Depend On Who Is Allowed To Trade.
Kalshi's launch of clinical-trial prediction markets creates a novel regulatory challenge at the intersection of federal derivatives law, pharmaceutical development, and information asymmetry.
Gesmer Updegrove LLP